- 
             Something wrong with this record ?
 
Expression of Opioid Receptors in Cells of the Immune System
J. Brejchova, V. Holan, P. Svoboda
Language English Country Switzerland
Document type Journal Article, Review
        Grant support
          
              LTAUSA18110 
          
      Ministerstvo Školství, Mládeže a Tělovýchovy   
      
          
              19-02290S 
          
      Grantová Agentura České Republiky   
      
      
 NLK 
   
      Free Medical Journals
   
    from 2000
   
      Freely Accessible Science Journals
   
    from 2000
   
      PubMed Central
   
    from 2007
   
      Europe PubMed Central
   
    from 2007
   
      ProQuest Central
   
    from 2000-03-01
   
      Open Access Digital Library
   
    from 2000-01-01
   
      Open Access Digital Library
   
    from 2007-01-01
   
      Health & Medicine (ProQuest)
   
    from 2000-03-01
   
      ROAD: Directory of Open Access Scholarly Resources
   
    from 2000
    
    PubMed
          
           33396783
           
          
          
    DOI
          
           10.3390/ijms22010315
           
          
          
  
    Knihovny.cz E-resources
    
  
              
      
- MeSH
- Biomarkers MeSH
- Chronic Pain drug therapy etiology metabolism MeSH
- Immune System drug effects immunology metabolism MeSH
- Stem Cells drug effects metabolism MeSH
- Humans MeSH
- Analgesics, Opioid pharmacology MeSH
- Receptors, Opioid genetics metabolism MeSH
- Gene Expression Regulation * MeSH
- Inflammation complications etiology metabolism MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
The observation of the immunomodulatory effects of opioid drugs opened the discussion about possible mechanisms of action and led researchers to consider the presence of opioid receptors (OR) in cells of the immune system. To date, numerous studies analyzing the expression of OR subtypes in animal and human immune cells have been performed. Some of them confirmed the expression of OR at both the mRNA and protein level, while others did not detect the receptor mRNA either. Although this topic remains controversial, further studies are constantly being published. The most recent articles suggested that the expression level of OR in human peripheral blood lymphocytes could help to evaluate the success of methadone maintenance therapy in former opioid addicts, or could serve as a biomarker for chronic pain diagnosis. However, the applicability of these findings to clinical practice needs to be verified by further investigations.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019611
- 003
- CZ-PrNML
- 005
- 20210830101208.0
- 007
- ta
- 008
- 210728s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms22010315 $2 doi
- 035 __
- $a (PubMed)33396783
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Brejchova, Jana $u Laboratory of Biomathematics, Institute of Physiology of the Czech Academy of Sciences, 14220 Prague, Czech Republic
- 245 10
- $a Expression of Opioid Receptors in Cells of the Immune System / $c J. Brejchova, V. Holan, P. Svoboda
- 520 9_
- $a The observation of the immunomodulatory effects of opioid drugs opened the discussion about possible mechanisms of action and led researchers to consider the presence of opioid receptors (OR) in cells of the immune system. To date, numerous studies analyzing the expression of OR subtypes in animal and human immune cells have been performed. Some of them confirmed the expression of OR at both the mRNA and protein level, while others did not detect the receptor mRNA either. Although this topic remains controversial, further studies are constantly being published. The most recent articles suggested that the expression level of OR in human peripheral blood lymphocytes could help to evaluate the success of methadone maintenance therapy in former opioid addicts, or could serve as a biomarker for chronic pain diagnosis. However, the applicability of these findings to clinical practice needs to be verified by further investigations.
- 650 _2
- $a opioidní analgetika $x farmakologie $7 D000701
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biologické markery $7 D015415
- 650 _2
- $a chronická bolest $x farmakoterapie $x etiologie $x metabolismus $7 D059350
- 650 12
- $a regulace genové exprese $7 D005786
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunitní systém $x účinky léků $x imunologie $x metabolismus $7 D007107
- 650 _2
- $a zánět $x komplikace $x etiologie $x metabolismus $7 D007249
- 650 _2
- $a receptory opiátové $x genetika $x metabolismus $7 D011957
- 650 _2
- $a kmenové buňky $x účinky léků $x metabolismus $7 D013234
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Holan, Vladimir $u Department of Nanotoxicology and Molecular Epidemiology, Institute of Experimental Medicine of the Czech Academy of Sciences, 14220 Prague, Czech Republic $u Department of Cell Biology, Faculty of Science, Charles University, 12843 Prague, Czech Republic
- 700 1_
- $a Svoboda, Petr $u Laboratory of Biomathematics, Institute of Physiology of the Czech Academy of Sciences, 14220 Prague, Czech Republic
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 22, č. 1 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33396783 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101208 $b ABA008
- 999 __
- $a ok $b bmc $g 1690437 $s 1140057
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 22 $c 1 $e 20201230 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- GRA __
- $a LTAUSA18110 $p Ministerstvo Školství, Mládeže a Tělovýchovy
- GRA __
- $a 19-02290S $p Grantová Agentura České Republiky
- LZP __
- $a Pubmed-20210728
